Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Award Notice

NHS National Pharmaceuticals Transition 2019_2

  • First published: 06 March 2020
  • Last modified: 06 March 2020
  • Version: N/A
  •  

  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Contents

Summary

OCID:
Published by:
The NHS Commissioning Board (operating under the name of NHS England)
Authority ID:
AA73994
Publication date:
06 March 2020
Deadline date:
-
Notice type:
Contract Award Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

NHS National Pharmaceuticals Transition 2019_2

Offer reference number: CM/PHG/17/5548

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 42 months potential periods of call-offs under the framework agreement:

NWLN: 1 February 2020 to 30 September 2020 (8 months)

LSNE: 1 February 2020 to 28 February 2021 (13 months)

CESW: 1 February 2020 to 31 October 2021 (21 months).

Full notice text

Contract award notice

Results of the procurement procedure

Section I: Contracting entity

I.1) Name and addresses

The NHS Commissioning Board (operating under the name of NHS England)

2nd Floor, Rutland House

Runcorn

WA7 2ES

UK

Contact person: David Ford

E-mail: david.ford1@nhs.net

NUTS: UK

Internet address(es)

Main address: https://nhsengland.bravosolution.co.uk

I.4) Type of the contracting authority

Ministry or any other national or federal authority, including their regional or local subdivisions

I.5) Main activity

Health

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

NHS National Pharmaceuticals Transition 2019_2

Reference number: CM/PHG/17/5548

II.1.2) Main CPV code

33600000

 

II.1.3) Type of contract

Supplies

II.1.4) Short description

NHS National Pharmaceuticals Transition 2019_2

Offer reference number: CM/PHG/17/5548

Period of framework agreement: the total maximum duration of the framework agreement to be no more than 42 months

Potential periods of call-offs under the framework agreement:

NWLN: 1 February 2020 to 30 September 2020 (8 months)

LSNE: 1 February 2020 to 28 February 2021 (13 months)

CESW: 1 February 2020 to 31 October 2021 (21 months).

Products on the framework include (but are not limited to):

Azacitadine

Colesevelam hcl

Deferiprone

Ezetimibe + simvastatin

Fosamprenavir calcium

Lopinavir + ritonavir

Oxybutinin patches

Parecoxib

Posaconazole

Roflumilast

Sodium oxybate

Vildagliptin + metformin

Vinflunine ditartrate

Vinorelbine (oral).

II.1.6) Information about lots

This contract is divided into lots: Yes

II.1.7) Total value of the procurement

Value excluding VAT: 80 823 466.00  GBP

II.2) Description

Lot No: 01

II.2.1) Title

NWLN: 1 February 2020 to 30 September 2020 (8 Months)

II.2.2) Additional CPV code(s)

33600000

33690000

II.2.3) Place of performance

NUTS code:

UKD

UKH

UKI


Main site or place of performance:

Please refer to Document 3, Schedule 8 in the ITO Documents for the list of purchasing points.

II.2.4) Description of the procurement

NHS National Pharmaceuticals Transition 2019_2

Offer reference number: CM/PHG/17/5548

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 42 months potential periods of call-offs under the framework agreement:

NWLN: 1 February 2020 to 30 September 2020 (8 months)

LSNE: 1 February 2020 to 28 February 2021 (13 months)

CESW: 1 February 2020 to 31 October 2021 (21 months).

II.2.5) Award criteria

Cost criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents / Weighting: See Tender

II.2.11) Information about options

Options: Yes

Description of options:

This framework has the options for the NWLN region to extend for up to a maximum of 8 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 02

II.2.1) Title

LSNE: 1 February 2020 to 28 February 2021 (13 Months)

II.2.2) Additional CPV code(s)

33600000

33690000

II.2.3) Place of performance

NUTS code:

UKC

UKE

UKI

UKJ


Main site or place of performance:

Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.

II.2.4) Description of the procurement

NHS National Pharmaceuticals Transition 2019_2

Offer reference number: CM/PHG/17/5548

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 42 months potential periods of call-offs under the framework agreement:

NWLN: 1 February 2020 to 30 September 2020 (8 months)

LSNE: 1 February 2020 to 28 February 2021 (13 months)

CESW: 1 February 2020 to 31 October 2021 (21 months).

II.2.5) Award criteria

Cost criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents / Weighting: See tender

II.2.11) Information about options

Options: Yes

Description of options:

This framework has the options for the LSNE region to extend for up to a maximum of 13 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Lot No: 03

II.2.1) Title

CESW: 1 February 2020 to 31 October 2021 (21 Months)

II.2.2) Additional CPV code(s)

33600000

33690000

II.2.3) Place of performance

NUTS code:

UKF

UKG

UKK


Main site or place of performance:

Please refer to Document 3, Schedule 8 in the ITO documents for the list of purchasing points.

II.2.4) Description of the procurement

NHS National Pharmaceuticals Transition 2019_2

Offer reference number: CM/PHG/17/5548

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 42 months potential periods of call-offs under the framework agreement:

NWLN: 1 February 2020 to 30 September 2020 (8 months)

LSNE: 1 February 2020 to 28 February 2021 (13 months)

CESW: 1 February 2020 to 31 October 2021 (21 months).

II.2.5) Award criteria

Cost criterion: Price is not the only award criterion and all criteria are stated only in the procurement documents / Weighting: See tender

II.2.11) Information about options

Options: Yes

Description of options:

This framework has the options for the CESW region to extend for up to a maximum of 21 months.

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.3) Information about a framework agreement or a dynamic purchasing system

The procurement involves the establishment of a framework agreement

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: Yes

IV.2) Administrative information

IV.2.1) Previous publication concerning this procedure

Notice number in the OJ S:

2019/S 184-447386

Section V: Award of contract

Lot No: 01

Contract No: CM/PHG/17/5548

Title: NWLN: 1 February 2020 to 30 September 2020 (8 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

Number of tenders received by electronic means: 21

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Accord UK Ltd

Barnstaple

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 27 239 798.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 01

Contract No: CM/PHG/17/5548

Title: NWLN: 1 February 2020 to 30 September 2020 (8 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Drugsrus

Northwood Hills

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 27 239 798.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 01

Contract No: CM/PHG/17/5548

Title: NWLN: 1 February 2020 to 30 September 2020 (8 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Merck Sharp and Dohme Ltd (MSD)

Hoddeston

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 27 239 798.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 01

Contract No: CM/PHG/17/5548

Title: NWLN: 1 February 2020 to 30 September 2020 (8 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Pierre Fabre Ltd

London

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 27 239 798.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 01

Contract No: CM/PHG/17/5548

Title: NWLN: 1 February 2020 to 30 September 2020 (8 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Seacross Pharmaceuticals Ltd

London

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 27 239 798.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Contract No: CM/PHG/17/5548

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

Number of tenders received by electronic means: 21

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Accord UK Ltd

Barnstaple

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Contract No: CM/PHG/17/5548

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Consilient Health

Richmond upon Thames

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Contract No: CM/PHG/17/5548

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Macarthys Laboratories t/a Martindale Pharma

Romford

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Merck Sharp & Dohme Ltd (MSD)

Hoddeston

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Mylan UK Healthcare

Potters Bar

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Sandoz Ltd

Camberley

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 02

Title: LSNE: 1 February 2020 to 28 February 2021 (13 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Zentiva Pharma UK Limited

Guildford

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 20 566 028.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 03

Contract No: CM/PHG/17/5548

Title: CESW: 1 February 2020 to 31 October 2021 (21 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

Number of tenders received by electronic means: 21

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Accord UK Ltd

Barnstaple

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 33 017 640.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 03

Title: CESW: 1 February 2020 to 31 October 2021 (21 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Consilient Health

Richmond upon Thames

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 33 017 640.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 03

Title: CESW: 1 February 2020 to 31 October 2021 (21 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Mylan UK Healthcare Limited

Potters Bar

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 33 017 640.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 03

Title: CESW: 1 February 2020 to 31 October 2021 (21 Months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Thornton and Ross Ltd

Huddersfield

UK

NUTS: UK

The contractor is an SME: No

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 33 017 640.00  GBP

V.2.5) Information about subcontracting

Section V: Award of contract

Lot No: 03

Title: CESW: 1 February 2020 to 31 October 2021 (21 months)

A contract/lot is awarded: Yes

V.2 Award of contract

V.2.1) Date of conclusion of the contract

15/01/2020

V.2.2) Information about tenders

Number of tenders received: 21

Number of tenders received from SMEs: 8

The contract has been awarded to a group of economic operators: No

V.2.3) Name and address of the contractor

Ascend Laboratories UK Ltd

London

UK

NUTS: UK

The contractor is an SME: Yes

V.2.4) Information on value of the contract/lot (excluding VAT)

Total value of the contract/lot: : 33 017 640.00  GBP

V.2.5) Information about subcontracting

Section VI: Complementary information

VI.3) Additional information

Please see list of awarded suppliers (Including SME status) at the following website: https://www.gov.uk/contracts-finder

VI.4) Procedures for review

VI.4.1) Review body

The Royal Courts of Justice

London or any other district registry of the High Court

UK

VI.5) Date of dispatch of this notice

02/03/2020

Coding

Commodity categories

ID Title Parent category
33600000 Pharmaceutical products Medical equipments, pharmaceuticals and personal care products
33690000 Various medicinal products Pharmaceutical products

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
david.ford1@nhs.net
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.